Skip to main content

Thalassemia News

Related terms: Alpha Thalassemia, Cooley's anemia, Mediterranean anemia

Chiesi Group Receives FDA Approval for Ferriprox (deferiprone) Twice-a-Day Tablets

BOSTON, May 21, 2020 (GLOBE NEWSWIRE) – Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), today announced...

FDA Approves Reblozyl (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular Red Blood Cell Transfusions

SUMMIT, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced the U.S. Food and Drug Administration (FDA) has approved...

FDA Approves Exjade to Remove Excess Iron in Patients with Genetic Blood Disorder

January 23, 2013 – The U.S. Food and Drug Administration today expanded the approved use of Exjade (deferasirox) to treat patients ages 10 years and older who have chronic iron overload resulting...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Anemia